Announcement: FDA Updates Alli Weight Loss Drug Label with Kidney Injury Warning

Last updated: 03/07/2026 14:43

0 Min Read

FDA mandates new kidney injury warnings on alli weight loss drug labels. The updated labeling requires consumers to consult healthcare providers before use if they have kidney disease history. — "OTC weight loss drugs" by Clean Wal-Mart is licensed under CC BY 2.0. To view a copy of this license, visit https://creativecommons.org/licenses/by/2.0/. (CC BY 2.0)

1 min read|46 words

🚨 FDA updates safety labeling for alli weight loss drug with new kidney injury warnings. The popular OTC medication now requires healthcare provider consultation for those with kidney disease history. Important safety update for millions using orlistat for weight management.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: FDA Updates Alli Weight Loss Drug Label with Kidney Injury Warning →

Share This Article

ByProf. Giorgi Pkhakadze

Follow:

Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Announcement: FDA Updates Alli Weight Loss Drug Label with Kidney Injury Warning

Submit Your Paper →

Ethiopia Study Reveals Stakeholder Concerns Over Novel Malaria Treatments

Sitafloxacin monotherapy matches doxycycline-rifampicin for brucellosis treatment in landmark trial

Ultra-processed foods linked to higher kidney cancer risk in large US study

Submit Your Paper to GMJ

Company

You Might Also Like